Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again
Regencell Bioscience shares fell 20.6% to $35.01 in Tuesday afternoon trading, with about 600,000 shares changing hands. The drop follows a recent Nasdaq volatility pause and comes after the company warned of “extreme price and volume fluctuations” and regulatory scrutiny in its latest annual report. The broader market edged lower, with the S&P 500 ETF down 0.3%.